Reports said investors were reconsidering the company’s IPO valuation ambitions amid a broader pullback in AI-related stocks.

Reuters reported on Nov. 5 that investors were questioning whether Anthropic could proceed with its planned IPO roadshow next week and list in November, as a tech-stock selloff weakened appetite for AI offerings. Some investors see the roughly $1.5 trillion valuation under discussion as too high; earlier expectations had reached $2 trillion. The offering could raise as much as $100 billion, though its size, price and timing remain unsettled. A lower valuation—or a delay—would test public-market confidence in AI companies and affect Anthropic’s backers, prospective shareholders and rivals seeking to raise capital. The pressure comes as more than 50 S&P 1500 technology stocks fell at least 10%, while investors also weighed whether massive AI spending will translate into profits. Anthropic, maker of Claude, has been preparing a Nasdaq listing under ticker ANT; it filed for an IPO in October and is targeting a mid-November debut. Earlier this year, investors reportedly anticipated an October listing at up to $2 trillion.